Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia

This publication has 55 references indexed in Scilit:

• Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies
  Atherosclerosis, 1992
• Differential effects of nicotinic acid in subjects with different LDL subclass patterns
  Atherosclerosis, 1992
• Efficacy and safety of pravastatin in patients with primary hypercholesterolemia
  Atherosclerosis, 1990
• Lipoprotein (a). Heterogeneity and biological relevance.
  Journal of Clinical Investigation, 1990
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
  Archives of internal medicine (1960), 1988
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE
  The Lancet, 1981
• Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.
  Circulation, 1979